These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10298342)

  • 1. Tenth Circuit upholds HHS experimental competitive bidding proposal for Medicare intermediary services; defers to "reasonable" agency readings of law.
    Kemezys KP
    Health Law Vigil; 1981 Dec; 4(25):7-9. PubMed ID: 10298342
    [No Abstract]   [Full Text] [Related]  

  • 2. U.S. court stops HEW's selection of intermediary.
    Hospitals; 1979 Dec; 53(23):18. PubMed ID: 387571
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare: criteria and standards for evaluating intermediary and carrier performance during fiscal year 1989--HCFA. General notice with comment period.
    Fed Regist; 1988 Sep; 53(177):35378-83. PubMed ID: 10302820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health insurer blasts pro-competition bill.
    Johnson DE
    Mod Healthc; 1981 Oct; 11(10):27-8. PubMed ID: 10252863
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare program, data, standards and methodology used to establish budgets for fiscal intermediaries and carriers--HCFA. Final notice with comment period.
    Fed Regist; 1989 Oct; 54(205):43493-500. PubMed ID: 10303982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare program; freestanding home health agencies to designated regional intermediaries; assignment and reassignment--HCFA. Final notice.
    Fed Regist; 1986 Feb; 51(30):5403-12. PubMed ID: 10300573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capital reimbursement issue sparks controversy; HHS proposal due soon.
    Wallace C
    Mod Healthc; 1984 Nov; 14(15):26-9. PubMed ID: 10299792
    [No Abstract]   [Full Text] [Related]  

  • 8. Supreme court rules that an agreement between insurer and a peer review organization is not exempt from antitrust scrutiny.
    Moses RJ
    Health Law Vigil; 1982 Jul; 5(15):4-5. PubMed ID: 10256012
    [No Abstract]   [Full Text] [Related]  

  • 9. Other agencies to bar professionals from influencing their industries unduly.
    Schlag DW
    Hosp Financ Manage; 1979 Mar; 33(3):52. PubMed ID: 10240571
    [No Abstract]   [Full Text] [Related]  

  • 10. The Freedom of Information Act and Medicare costs reports.
    Shulman LJ
    Am J Law Med; 1981; 6(4):543-58. PubMed ID: 7032285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition--the claims and the controversy.
    Sandrick KM
    QRB Qual Rev Bull; 1982 Mar; 8(3):2-5. PubMed ID: 6804910
    [No Abstract]   [Full Text] [Related]  

  • 12. An interview with Dr. Robert J. Rubin. Interview by Walter R. Nathan.
    Rubin RJ
    Hosp Manage Q; 1981; ():19-21. PubMed ID: 10269366
    [No Abstract]   [Full Text] [Related]  

  • 13. Self-insurance--now more viable.
    Quinley WW
    Hosp Financ Manage; 1977 Nov; 31(11):20-1. PubMed ID: 10305243
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspectives. Medigap industry under scrutiny.
    Firshein J
    Mcgraw Hills Med Health; 1989 Jun; 43(24):suppl 4 p.. PubMed ID: 10303631
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare program; reasonable charge limitations--HCFA. Final rule with comment period.
    Fed Regist; 1986 Aug; 51(154):28710-7. PubMed ID: 10300984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives. Medigap market melee: next round.
    Mjoseth J
    Faulkner Grays Med Health; 1990 Jun; 44(23):suppl 4 p.. PubMed ID: 10106658
    [No Abstract]   [Full Text] [Related]  

  • 17. The reasonable and necessary criterion and Medicare contractor review of claims: efforts to combat fraud, waste and abuse in the Medicare program.
    Nicholson G; Robins L
    Spec Law Dig Health Care Law; 2000 Feb; (251):9-18. PubMed ID: 10747458
    [No Abstract]   [Full Text] [Related]  

  • 18. Privacy Act of 1974; notice of new routine uses--HCFA. Notification of new routine uses.
    Fed Regist; 1983 Jul; 48(130):31092-8. PubMed ID: 10299122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competition in health insurance markets.
    Pauly MV
    Law Contemp Probl; 1988; 51(2):237-71. PubMed ID: 10295964
    [No Abstract]   [Full Text] [Related]  

  • 20. An antitrust exemption for commercial insurers? Answer: no.
    Goldberg LG; Greenberg W
    Rev Fed Am Hosp; 1984; 17(1):84, 87. PubMed ID: 10265081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.